CVi delivers the power to improve patient safety, minimizing the risk of contrast-induced acute kidney injury (CI-AKI) for coronary catheterizations when compared to manual injection of contrast media.

It’s the contrast injector for:

  • Interventional cardiologists who want to regulate contrast injection flow and minimize risk of CI-AKI—also referred to as contrast induced nephropathy (CIN)
  • Hospital administrators interested in cost containment through cath lab safety and efficiency and reducing potential patient post-procedure adverse events

Increasing safety and operational efficiency

CVi increases patient and workplace safety, as well as operational efficiency.

Increasing patient safety

Up to 30% reduction in CI-AKI vs. manual injection.

CI-AKI incremental cost range: $13,294 to $14,266.2*

Increasing patient safety

~25% reduction in contrast use without compromising image quality when comparing 4 Fr to 6 Fr diagnostic procedures.3

Bleeding and contrast use were significantly reduced with 5 Fr catheters compared to 6 Fr.4

Increasing workplace safety

Up to 50% reduction in clinician radiation exposure by stepping back.5,6

Increasing workplace safety

49.4% of interventional cardiologists have experienced at least one orthopedic injury.7

Manual contrast injection may cause repetitive stress injuries to the operator’s hand based on the force required to inject contrast and the number of procedures performed per day.8

Increasing operational efficiency

45 mL decrease per case when injector used.9

There is up to $0.30/mL savings in wasted contrast media.

Increasing operational efficiency

Average 5 min faster per procedure10

Time saved may allow for additional procedures to be performed in a day.10

*P<0.05 CVi vs. manual injection

Watch the overview

See system highlights and other CVi features.

Interested in learning more?

Contact a rep to learn more about ACIST CVi.

Find a rep